| 000 | 01754 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250516201955.0 | ||
| 264 | 0 | _c20150330 | |
| 008 | 201503s 0 0 eng d | ||
| 022 | _a1442-9071 | ||
| 024 | 7 |
_a10.1111/ceo.12311 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGado, Ahmed S | |
| 245 | 0 | 0 |
_aDexamethasone intravitreous implant versus bevacizumab for central retinal vein occlusion-related macular oedema: a prospective randomized comparison. _h[electronic resource] |
| 260 |
_bClinical & experimental ophthalmology _c |
||
| 300 |
_a650-5 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAngiogenesis Inhibitors _xtherapeutic use |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal, Humanized _xtherapeutic use |
| 650 | 0 | 4 | _aBevacizumab |
| 650 | 0 | 4 |
_aDexamethasone _xadministration & dosage |
| 650 | 0 | 4 | _aDrug Implants |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFluorescein Angiography |
| 650 | 0 | 4 |
_aGlucocorticoids _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIntraocular Pressure |
| 650 | 0 | 4 | _aIntravitreal Injections |
| 650 | 0 | 4 |
_aMacular Edema _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 |
_aRetinal Vein Occlusion _xcomplications |
| 650 | 0 | 4 | _aTomography, Optical Coherence |
| 650 | 0 | 4 |
_aVascular Endothelial Growth Factor A _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aVisual Acuity _xdrug effects |
| 700 | 1 | _aMacky, Tamer A | |
| 773 | 0 |
_tClinical & experimental ophthalmology _gvol. 42 _gno. 7 _gp. 650-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/ceo.12311 _zAvailable from publisher's website |
| 999 |
_c23624168 _d23624168 |
||